ArticleRSC medicinal chemistry2026

Comprehensive multi-omics analysis and experimental validation indicate that VPS35 is a promising biomarker for prognosis, immunotherapy, and chemotherapy in LIHC.

Dan Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.